Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12930555 | 0.89 | FASN (0.43) | FASNDGAT1 | |
| SCHEMBL15460692 | 0.84 | FASN (0.32) | FASN | |
| SCHEMBL15460828 | 0.82 | FASN (0.32) | FASN | |
| SCHEMBL15460862 | 0.80 | FASN (0.37) | FASN | |
| SCHEMBL12930554 | 0.80 | FASN (0.51) | FASNDGAT1 | |
| SCHEMBL16591211 | 0.80 | FASN (0.51) | FASNDGAT1 | |
| SCHEMBL14621251 | 0.79 | FASN (0.48) | FASNDGAT1 | |
| SCHEMBL15460827 | 0.78 | — | — | |
| SCHEMBL15744345 | 0.78 | FASN (0.47) | FASNDGAT1 | |
| SCHEMBL13198641 | 0.78 | CYP2C9 (0.44) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8585922-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20110001090-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-01-06 | — | — | US | disclosed |
| US-20110001090-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110001090-A1 | LIQUID-CRYSTALLINE MEDIUM | CHRM1, EML4, L1CAM | FASN 4509/4885DGAT1 4700/4885KDM1A 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.